Refine by
Patient Database Articles & Analysis
7 news found
Indication Expansion: The Cellworks Platform can potentially identify additional indications where an investigational drug may be effective by leveraging the Cellworks patient database of 100,000+ omics patient profiles and 1,800 oncology cell-lines to evaluate the efficacy of the agent in other indications. ...
Doctors save time because they no longer have to cross-reference separate databases. The patient spends less time in the chair because all aspects of the exam have been streamlined. ...
Particularly in comparison to a single biomarker test, the chance to comprehensively test and predict patient responses to a variety of treatments provides significant benefit to patients and doctors and ultimately delivers accurate decision support on the most effective treatment options.” The clinical interpretation will be supported by OncoDNA ...
MOUNTAIN VIEW, Calif., January 13, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Wireless Patch System (WPS) for non-invasive myoelectric activity measurement. ...
"We chose them because their technologies solve important patient needs and have great market potential, and we think their teams can get the job done. ...
“We chose them because their technologies solve important patient needs and have great market potential, and we think their teams can get the job done. ...
The key aspect of the invention is that the individual patient strain data are compared regionally within the left ventricle of the heart to a “normal” patient SQuEEZ database that was compiled by the inventors. Using this database information, each patient-specific SQuEEZ value at each of the points ...